Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
25.03.24
/
50%
€16.50
Target price
25.03.25
€23.06
Performance (%)
-4.67%
End price
26.03.25
€15.73
Summary
This prediction ended on 26.03.25 with a price of €15.73. With a performance of -4.67%, the BUY prediction for Acadia Pharmaceuticals by JPMorgan_Chase___Co_ closed slightly in the red. JPMorgan_Chase___Co_ has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 1.733% | 1.733% | 37.677% |
| iShares Core DAX® | 1.867% | 3.031% | 27.591% |
| iShares Nasdaq 100 | 1.427% | 5.634% | 18.496% |
| iShares Nikkei 225® | 5.007% | 9.538% | 13.427% |
| iShares S&P 500 | 1.241% | 4.277% | 12.130% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at JPMorgan Chase & Co. from $29.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
-4.10%
07.10.25
07.10.25
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.17
29.09.25
29.09.25
€28.15
29.09.26
29.09.26
1.76%
07.10.25
07.10.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
24.07.25
24.07.25
€28.88
24.07.26
24.07.26
-7.55%
07.10.25
07.10.25